Post by Agilent Technologies

As therapeutic peptides, especially GLP-1 based therapeutics gain momentum, the need for deeper characterization, higher throughput, and reliable quality data continues to grow. Access practical guidance to help you speed analysis, reduce ambiguity, and ensure product quality throughout the development process. Download brochure: https://bit.ly/4vE59RB #GLP-1 #impurity #biopharmaworkflows #analyticalchemistry